abstract |
The present invention relates to the use of ligands of a high affinity binding site of diisopropyl fluorophosphate (DFP) on brain membranes for the prophylaxis and treatment of diseases of the central nervous system, in particular cognitive disorders, depression, schizophrenia and anxiety. |